nexium sales billion





He said IMS Health, which tracks prescription drug sales and trends, reported that the
British drugmaker reaped more than $6 billion in U.S. Nexium sales in .
The two drugs are AstraZeneca most profitable with $1.652 billion in sales for Losec and Prilosec and $4.633 billion in sales for Nexium. AstraZeneca claims that .
The drugmaker expects a ``mid-single digit decline'' in worldwide Nexium sales for 2008, Lowth said. Seroquel gained 14 percent to $1.1 billion, below the .
AstraZeneca
. in March, while the patent on Nexium for ulcers, the third-biggest seller, expires in 2014. The two probably generated $5.6 billion and $4.5 billion in sales .
And IMS Health, a company that tracks pharmaceutical sales, reports that Nexium earned more than $5 billion in sales in the U.S. last year, making it the .
Nexium is AstraZeneca
Last week's report from IMS Health on stagnating drug sales also included . Lipitor, Pfizer, cholesterol, $7.8 billion, down from $8.1 billion in 2007 Nexium, AstraZeneca .
Nexium sales already fell short of some expectations in the most recent quarter at $1.31 billion. AstraZeneca has endured a series of late-stage product setbacks and .
The heartburn drug Prilosec is one of the best-selling prescription medicines in history. Sales in nexium sales billion the past five years alone amount to $26 billion.
NEXIUM capsules
nexium sales billion
have been launched in 89 countries. Worldwide NEXIUM sales totalled $3.9 billion in 2004, with US sales reaching $2.7 billion.
The biggest surprise, to me, is in the second-place spot: Nexium, the purple pill from AstraZeneca, which generated $6.3 billion in sales, according to IMS.
By contrast, AstraZeneca's total
.Related links: can i chew my xanax videosxxxcalientes